Cancer
| 3 min read
A physics-based urine test shows early promise in detecting bladder cancer recurrence without invasive procedures.
| 3 min read
Phase 2 trial shows that a topical drug rapidly reduces malodor, pain, and improves quality of life for patients with malignant fungating wounds.
| 4 min read
Preclinical systems such as patient-derived xenografts are providing unprecedented insight into tumor biology and helping bridge the gap between discovery and clinical translation.
| 4 min read
Investments in solid tumor targets and autoimmune disease, success for a peanut allergy patch, a promising CAR T cell therapy for stiff person syndrome, and more led the news this week.
| 9 min read
Rather than replacing radiologists, AI is working alongside them to catch cancers earlier and improve screening efficiency.
| 5 min read
Early clinical data suggest that intratumoral delivery may halt tumor activity and support bone regeneration in metastatic breast cancer.
| 3 min read
QDX and Prelude Therapeutics are developing drugs that selectively target the JAK2 V617F mutation, offering hope for patients with myeloproliferative neoplasms.
| 3 min read
Scientists created a novel platform that uses the advantages of both bacteria and viruses to attack tumors.
| 4 min read
A new deep learning model combines dermoscopic images with patient data to improve accuracy and reduce false positives.
| 2 min read
The new investment accelerates development of a potential breakthrough therapy targeting the one-carbon metabolic pathway.
| 4 min read
Rare disease approvals, multi-billion-dollar deals, and more led this week’s headlines.
| 4 min read
Early clinical trials show that a KRAS G12D inhibitor can shrink tumors in patients with advanced pancreatic and other solid cancers.
